EUVIMEDOpdag EUVIMED
Open access

Cooperativity and communication between the active sites of the dimeric SARS-CoV-2 main protease

Sarah N Zvornicanin iD, Ala M Shaqra iD, Julia Flynn iD, Lauren E Intravaia iD, Heidi Carias Martinez iD, Weiping Jia, Devendra Kumar Gupta, Stephanie Moquin iD, Dustin Dovala iD, Daniel N Bolon iD, Brian A Kelch iD, Celia A Schiffer iD and 1 more

Science Advances · 2026

DOI: 10.1126/sciadv.aeb0769 ↗

At a glance

Journal article in Science Advances, 2026. Written by Sarah N Zvornicanin and 12 co-authors. Institution: Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Major MEDLINE topics: Coronavirus 3C Proteases, SARS-CoV-2. Cited 5 times so far (Crossref); 47 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The coronaviral main protease (M pro ) has been the subject of various biochemical and structural studies and a drug target against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. SARS-CoV-2 M pro is active as a dimer, but despite apparent cooperativity in catalytic activity, how the two distal active sites communicate and modulate binding and/or catalysis is unclear. Here, we have investigated the interplay between cooperativity, dimerization, and substrate cleavage in SARS-CoV-2 M pro through a combination of enzymatic assays, crystal structures, and protein characterization. To disentangle the contribution of each active site to the observed enzymatic activity, we developed a cleavage assay involving heterodimers of active and inactive (catalytic residue mutated or inhibitor-bound) monomers. Notably, we found that heterodimerization increased cleavage efficiency per active monomer. In addition, we mapped a network of critical residues bridging the two active sites and probed this network through engineered mutations. By dissecting the cooperativity and communication between the active sites, we provide insights into the M pro reaction cycle and functional significance of its dimeric architecture.

Subjects

MeSH terms (MEDLINE)

Coronavirus 3C ProteasesSARS-CoV-2Catalytic DomainProtein MultimerizationHumansModels, MolecularMutationCrystallography, X-RayProtein Binding

Substances

Coronavirus 3C Proteases

Authors and institutions

  • Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
  • Biomedical Research, Novartis, Emeryville, CA 94608, USA.

ORCID profiles: Sarah N Zvornicanin, Ala M Shaqra, Julia Flynn, Lauren E Intravaia, Heidi Carias Martinez, Stephanie Moquin, Dustin Dovala, Daniel N Bolon, Brian A Kelch, Celia A Schiffer, Nese Kurt Yilmaz

Funding

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Institute of Allergy and Infectious Diseases
  • Biomedical Sciences, Novartis

Cite

APA

Zvornicanin, S. N., Shaqra, A. M., Flynn, J., Intravaia, L. E., Martinez, H. C., Jia, W., Gupta, D. K., Moquin, S., Dovala, D., Bolon, D. N., Kelch, B. A., Schiffer, C. A., & Yilmaz, N. K. (2026). Cooperativity and communication between the active sites of the dimeric SARS-CoV-2 main protease. Science Advances. https://doi.org/10.1126/sciadv.aeb0769

Vancouver

Zvornicanin SN, Shaqra AM, Flynn J, Intravaia LE, Martinez HC, Jia W, et al. Cooperativity and communication between the active sites of the dimeric SARS-CoV-2 main protease. Science Advances. 2026. doi:10.1126/sciadv.aeb0769

BibTeX
@article{Zvornicanin2026,
  author = {Zvornicanin, Sarah N and Shaqra, Ala M and Flynn, Julia and Intravaia, Lauren E and Martinez, Heidi Carias and Jia, Weiping and Gupta, Devendra Kumar and Moquin, Stephanie and Dovala, Dustin and Bolon, Daniel N and Kelch, Brian A and Schiffer, Celia A and Yilmaz, Nese Kurt},
  title = {Cooperativity and communication between the active sites of the dimeric SARS-CoV-2 main protease},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aeb0769}
}
Start for free →